Fundraising FoxArboretum Ventures — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.
BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US
Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)inKaiyuan Yang(Founder)
Board seatThomas M. Shehab· per SEC Form D
Co-investorsDivergent CapitalDolby Family VenturesFeatures Capital HoldingsKdT VenturesPsyMed VenturesTMC Venture Fund+6 more
AtaCor Medical develops extravascular lead systems for cardiac rhythm management, including a novel extravascular defibrillation lead for EV-ICD therapy and an implantable, extracardiac pacemaker.
HardwareHealthtechMedical Devices
Alan(Co-founder & Vice President of Clinical, Regulatory & Quality)
Co-investorsBayMed Venture PartnersBroadview VenturesCatalyst Health VenturesHatteras Venture Partners
Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.
Digital HealthHealthtechMedical DevicesValencia, US
Manish Vaishya, PhD(Chief Executive Officer, Co-Founder & Board Member)Jill Schiaparelli(Executive Officer, Director)inKevin Wasserstein(Director)
BoardThomas Shehab, MD(Director)
Co-investorsAngelini VenturesAsahi Kasei Corporate Venture CapitalAvestria VenturesShangBay Capital LLC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.